Dr. Ihosvany Fernández-Bello | Molecular Biology | Best Researcher Award

Postdoctoral Assocoiated at Hospital General Universirario Dr Balmis, Spain.

Dr. Ihosvany Fernández Bello is a distinguished postdoctoral researcher and clinical trial coordinator with a strong focus on thrombosis and hemostasis. His career began in 2003 at the Thrombosis and Haemostasis Unit of the Hospital Universitario La Paz (HULP) in Madrid, where he worked as the Clinical Trials Coordinator until 2019. He has extensive experience in utilizing advanced techniques for evaluating hemostasis, including Rotational Thromboelastometry (ROTEM), Thrombelastography (TEG), and Automated Calibrated Thrombinography (CAT). Dr. Fernández Bello is noted for his contributions to modifying these techniques to predict responses and thrombotic risks associated with disruptive therapies in hemophilia treatment.

Profile

Education

Dr. Fernández Bello holds a Licentiate degree in Pharmacy from the Universidad Complutense de Madrid and a Doctorate in Medicine and Surgery from the Universidad Autónoma de Madrid. His doctoral thesis focused on the prothrombotic state of Behçet’s disease, a rare condition, where he applied global hemostasis tests and studied the proinflammatory role of platelets.

Professional Experience

Dr. Ihosvany Fernández Bello has had a distinguished career, primarily focused on thrombosis and hemostasis. He began his journey as a Clinical Trials Coordinator at Hospital Universitario La Paz in Madrid in 2003. Over the years, he has developed and carried out numerous research projects, utilizing advanced techniques such as Rotational Thromboelastometry (ROTEM), Thrombelastography (TEG), and Automated Calibrated Thrombinography (CAT) to evaluate hemostasis. Dr. Fernández Bello has made significant contributions to modifying these techniques to better predict responses and thrombotic risks during the use of innovative therapies for hemophilia, such as emicizumab, concizumab, and Mim-8.

Teaching and Mentoring

In addition to his research work, Dr. Fernández Bello has been actively involved in teaching and mentoring. He has delivered numerous courses and training programs related to coagulation disorders, hemophilia, and thrombosis, both in Spain and internationally. His efforts in education have significantly contributed to the professional development of many healthcare professionals.

Conclusion

Dr. Ihosvany Fernández Bello’s extensive experience in clinical research, his innovative contributions to the field of hemostasis, and his commitment to education make him a highly suitable candidate for the Research for Best Researcher Award. His work has had a profound impact on the treatment of hemophilia and other coagulation disorders, earning him recognition both nationally and internationally. His dedication to advancing medical research and improving patient outcomes through innovative therapies aligns perfectly with the goals of the Research for Best Researcher Award.

Publications Top Notes

Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa
Authors: Sacedón, R., de Arriba, M.C., Martínez-Santamaría, L., Sánchez-Ramón, S., Escámez, M.J.
Journal: British Journal of Dermatology
Year: 2023
Citations: 0

Procoagulant State of Sleep Apnea Depends on Systemic Inflammation and Endothelial Damage
Authors: Fernández-Bello, I., Monzón Manzano, E., García Río, F., Jiménez Yuste, V., Butta, N.V.
Journal: Archivos de Bronconeumologia
Year: 2022
Citations: 28

Clot Stiffness Measured By Seer Sonorheometry As a Marker Of Poor Prognosis In Hospitalized COVID-19 Patients
Authors: López-Jaime, F.J., Fernández-Bello, I., Martín-Téllez, S., Muñoz-Pérez, M.I., Montaño, A.
Journal: Clinical and Applied Thrombosis/Hemostasis
Year: 2022
Citations: 0

Monitoring of new therapies for hemophilia
Authors: Fernández-Bello, I.
Journal: Blood Coagulation and Fibrinolysis
Year: 2022
Citations: 0

Insights into the procoagulant profile of patients with systemic lupus erythematosus without antiphospholipid antibodies
Authors: Manzano, E.M., Fernández-Bello, I., Sanz, R.J., Yuste, V.J., Butta, N.V.
Journal: Journal of Clinical Medicine
Year: 2020
Citations: 9

Clinical trials and Haemophilia during the COVID-19 pandemic: Madrid’s experience
Authors: Álvarez-Román, M.T., García-Barcenilla, S., Cebanu, T., Rivas-Pollmar, M.I., Jiménez-Yuste, V.
Journal: Haemophilia
Year: 2020
Citations: 7

Platelet and immune characteristics of immune thrombocytopaenia patients non-responsive to therapy reveal severe immune dysregulation
Authors: Monzón Manzano, E., Álvarez Román, M.T., Justo Sanz, R., Butta, N.V., Jiménez Yuste, V.
Journal: British Journal of Haematology
Year: 2020
Citations: 29

Evaluation of EC50 of factor VIII as predictor of prophylaxis efficacy in patients with severe haemophilia A
Authors: Fernández-Bello, I., Rode, F., Álvarez-Román, M.T., Larsen, L.F., Jiménez-Yuste, V.
Journal: European Journal of Pharmaceutical Sciences
Year: 2019
Citations: 0

Platelet Apoptosis and PAI-1 are Involved in the Pro-Coagulant State of Immune Thrombocytopaenia Patients Treated with Thrombopoietin Receptor Agonists
Authors: Justo Sanz, R., Monzón Manzano, E., Fernández Bello, I., Jiménez Yuste, V., Butta, N.V.
Journal: Thrombosis and Haemostasis
Year: 2019
Citations: 32

Immune thrombocytopenia – in defence of the platelet count. Response to Hill
Authors: Álvarez Román, M.T., Fernández Bello, I., Jiménez-Yuste, V., Justo Sanz, R., Butta, N.V.
Journal: British Journal of Haematology
Year: 2018
Citations: 0

Ihosvany Fernández-Bello | Molecular Biology | Best Researcher Award

Dr. Ihosvany Fernández-Bello | Molecular Biology | Best Researcher Award

Teaching and Mentoring

Conclusion

Publications Top Notes

RECOMMENDED

Mail us

Contact